⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Fosbretabulin Tromethamine (CA4P) in Combination With Paclitaxel and Carboplatin in Anaplastic Thyroid Carcinoma (FACT2)

Study ID: NCT01701349

Study Description

Brief Summary: This is a multicenter, double-blind, placebo-controlled, randomized study of fosbretabulin given with chemotherapy (paclitaxel and carboplatin) compared to placebo given with chemotherapy (paclitaxel and carboplatin) in subjects with anaplastic thyroid cancer (ATC). The primary objective of the study is to determine overall survival. A maximum of 300 subjects will be recruited from approximately 75 multinational sites of which approximately 35 will be located in the United States.

Detailed Description: The Treatment Plan followed for all subjects will consist of: * A Screening Visit within 14 days before study drug (fosbretabulin or placebo) administration * A Treatment Phase of 21-day combination treatment (study drug plus chemotherapy) cycles (up to 6 cycles) * An End of Treatment Phase assessment * An End of Study Visit occurring 30 days after the last day of study drug administration, as able After the last clinic visit, all subjects will be followed for survival by monthly phone calls, email, or in-person.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Contact Details

Name: Marcia Brose, MD, PhD

Affiliation: University of Pennsylvania, Philadelphia, PA 19104

Role: PRINCIPAL_INVESTIGATOR

Name: Julie A Sosa, MD

Affiliation: Yale University, New Haven, CT 06520

Role: PRINCIPAL_INVESTIGATOR

Name: Lisa Licitra, MD

Affiliation: Instituto Nazionale Per Lo Studio E La Cura Dei Tumori, Milan, Italy

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: